HIV patients get safer flu shot options in new study

NCT ID NCT01008813

First seen Apr 13, 2026 · Last updated May 16, 2026 · Updated 11 times

Summary

This study looked at two versions of the H1N1 flu vaccine in 306 adults with HIV. One vaccine had an extra ingredient (adjuvant) to boost the immune response, and the other did not. The goal was to see which vaccine was safer and worked better to protect against the flu. Participants received one or two shots and were monitored for a year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CIC de Vaccinologie Cochin Pasteur, hôpital Cochin

    Paris, 75679, France

  • Hopital du Kremlin Bicêtre Service de médecine interne

    Kremlin Bicëtre, 94275, France

  • Hôpital Gustave Dron, Service Maladies Infectieuses

    Tourcoing, 59208, France

  • Hôpital Henri Mondor

    Créteil, 94010, France

  • Hôpital Saint-Louis

    Paris, 75010, France

  • Service des Maladies Infectieuses et Tropicales, Hopital Tenon

    Paris, 75020, France

Conditions

Explore the condition pages connected to this study.